Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Respir Med. 2019 Mar;148:13-23. doi: 10.1016/j.rmed.2019.01.005. Epub 2019 Jan 17.
Various determinants of osteoporosis have been previously identified. However, only a few longitudinal studies have examined related factors. We aimed to investigate factors predicting and modifying rapid decline of bone mineral density in patients with chronic obstructive pulmonary disease.
We analyzed patients with chronic obstructive pulmonary disease whose bone mineral density were measured at least three times over three years (n = 111). We divided annual per cent changes of bone mineral density in different body parts into tertiles. Rapid decliners (n = 33) were defined as those with the largest decline in at least two parts; all other participants were defined as non-rapid decliners (n = 78).
At enrollment, bone mineral density did not differ between the two groups. However, rapid decliners had a significantly greater rate of new vertebral fractures over 3 years compared with non-rapid decliners. On multivariate logistic regression analysis, age, moderate to severe emphysema, no daily exercise habits, and anemia increased the likelihood of rapid decliners. Furthermore, patients who newly started and continued bisphosphonate exhibited higher annual per cent changes of bone mineral density than did those without bisphosphonate use.
A rapid decline in bone mineral density correlates to a higher likelihood of vertebral fracture. We clarified the predictors of bone mineral density decline and demonstrated that bisphosphonate use might modify bone mineral density in patients with chronic obstructive pulmonary disease.
先前已经确定了骨质疏松症的各种决定因素。然而,只有少数纵向研究检查了相关因素。我们旨在研究预测和改变慢性阻塞性肺疾病患者骨密度快速下降的因素。
我们分析了至少在三年内测量了三次骨密度的慢性阻塞性肺疾病患者(n=111)。我们将不同身体部位的骨密度每年的百分比变化分为三分位。快速下降者(n=33)定义为至少两个部位下降最大的患者;所有其他参与者定义为非快速下降者(n=78)。
在入组时,两组之间的骨密度没有差异。然而,快速下降者在 3 年内新发生的椎体骨折率明显高于非快速下降者。多元逻辑回归分析显示,年龄、中重度肺气肿、无每日运动习惯和贫血增加了快速下降者的可能性。此外,新开始并继续使用双膦酸盐的患者的骨密度年变化率高于未使用双膦酸盐的患者。
骨密度的快速下降与椎体骨折的可能性增加相关。我们阐明了骨密度下降的预测因素,并表明双膦酸盐的使用可能会改变慢性阻塞性肺疾病患者的骨密度。